-
41
Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
42
Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content
Published 2025-12-01Subjects: Get full text
Article -
43
Multi-omics analysis reveals the sensitivity of immunotherapy for unresectable non-small cell lung cancer
Published 2025-02-01Subjects: Get full text
Article -
44
Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy
Published 2025-02-01Subjects: Get full text
Article -
45
Clinical characteristics and potential biomarkers of thyroid and pituitary immune-related adverse events
Published 2024-01-01Subjects: Get full text
Article -
46
Editorial: Advances in immunotherapy of hepatic-biliary-pancreatic cancers, volume II
Published 2025-01-01Subjects: Get full text
Article -
47
Anti-HER2 biparatopic antibody KJ015 has near-native structure, functional balanced high affinity, and synergistic efficacy with anti-PD-1 treatment in vivo
Published 2024-12-01Subjects: “…combination therapy with immune checkpoint inhibitors (ICIs)…”
Get full text
Article -
48
Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors in patients with advanced malignant melanoma and non-small cell lung cancer
Published 2024-12-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
49
From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Published 2025-12-01Subjects: Get full text
Article -
50
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study
Published 2025-01-01Subjects: Get full text
Article -
51
Ginseng polysaccharides circumvent acquired resistance to anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Published 2025-02-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
52
Baseline 18F-FDG PET/CT parameters in predicting the efficacy of immunotherapy in non-small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
53
Case report: A severe myositis mimicking bulbar palsy after administration of immune checkpoint inhibitors
Published 2025-02-01Subjects: Get full text
Article -
54
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer
Published 2024-12-01Subjects: Get full text
Article -
55
Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
Published 2025-03-01Subjects: Get full text
Article -
56
-
57
-
58
-
59
Identifying factors for pembrolizumab eligibility in head and neck cancer
Published 2025-02-01Subjects: Get full text
Article -
60
Network Medicine‐Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD‐L1 Expression via Targeting SPOP in Cancer
Published 2025-01-01Subjects: Get full text
Article